Pierre Falardeau

5.0k total citations · 1 hit paper
95 papers, 4.0k citations indexed

About

Pierre Falardeau is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Biochemistry. According to data from OpenAlex, Pierre Falardeau has authored 95 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 28 papers in Cellular and Molecular Neuroscience and 18 papers in Biochemistry. Recurrent topics in Pierre Falardeau's work include Receptor Mechanisms and Signaling (24 papers), Neurotransmitter Receptor Influence on Behavior (16 papers) and Eicosanoids and Hypertension Pharmacology (15 papers). Pierre Falardeau is often cited by papers focused on Receptor Mechanisms and Signaling (24 papers), Neurotransmitter Receptor Influence on Behavior (16 papers) and Eicosanoids and Hypertension Pharmacology (15 papers). Pierre Falardeau collaborates with scholars based in Canada, United States and France. Pierre Falardeau's co-authors include Thérèse Di Paolo, Jay A. Gingrich, Marc G. Caron, Michael D. Bates, Robert T. Fremeau, Sven Hammarström, John A. Oates, R. Boucher, A R Brash and Garrett Fitzgerald and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Pierre Falardeau

92 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular cloning and expression of the gene for a human D1 dopamine receptor

1990 534 citations Jay A. Gingrich, Pierre Falardeau et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pierre Falardeau Canada	31	1.8k	1.7k	722	575	400	95	4.0k
Kiyoshi Kataoka Japan	38	2.2k 1.2×	1.6k 0.9×	342 0.5×	335 0.6×	189 0.5×	122	4.3k
Motohatsu Fujiwara Japan	31	1.3k 0.7×	2.1k 1.2×	207 0.3×	476 0.8×	211 0.5×	195	4.0k
G. Zürcher Switzerland	27	553 0.3×	888 0.5×	608 0.8×	261 0.5×	135 0.3×	42	3.0k
Shigenobu Nakamura Japan	35	2.5k 1.4×	2.6k 1.5×	1.7k 2.3×	327 0.6×	158 0.4×	102	5.0k
I Diamond United States	27	1.3k 0.7×	1.5k 0.9×	225 0.3×	241 0.4×	278 0.7×	56	3.2k
Devin Welty United States	17	2.1k 1.2×	1.3k 0.8×	426 0.6×	280 0.5×	257 0.6×	39	4.2k
Josep Saura Spain	35	1.3k 0.7×	1.4k 0.8×	871 1.2×	548 1.0×	129 0.3×	75	4.4k
Marina Pizzi Italy	42	1.8k 1.0×	2.1k 1.3×	992 1.4×	376 0.7×	114 0.3×	121	5.3k
Byoung Joo Gwag South Korea	41	2.2k 1.3×	2.9k 1.7×	623 0.9×	299 0.5×	97 0.2×	94	6.3k
Ana Patricia Fernández Spain	30	1.2k 0.7×	1.3k 0.8×	206 0.3×	271 0.5×	190 0.5×	72	3.9k

Countries citing papers authored by Pierre Falardeau

Since Specialization

Citations

This map shows the geographic impact of Pierre Falardeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Falardeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Falardeau more than expected).

Fields of papers citing papers by Pierre Falardeau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Falardeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Falardeau. The network helps show where Pierre Falardeau may publish in the future.

Co-authorship network of co-authors of Pierre Falardeau

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Falardeau. A scholar is included among the top collaborators of Pierre Falardeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Falardeau. Pierre Falardeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bertomeu, Thierry, Ashraf Ibrahim, Simone P. Zehntner, et al.. (2010). TLN-4601 peripheral benzodiazepine receptor (PBR/TSPO) binding properties do not mediate apoptosis but confer tumor-specific accumulation. Biochemical Pharmacology. 80(10). 1572–1579. 9 indexed citations

Falardeau, Pierre, et al.. (2009). Abstract #4408: M2PK mediates TLN-232 cytotoxicity. Cancer Research. 69. 4408–4408. 1 indexed citations

Latreille, Jean, Gerald Batist, Francis Laberge, et al.. (2003). Phase I/II Trial of the Safety and Efficacy of AE-941 (Neovastat®) in the Treatment of Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 4(4). 231–236. 40 indexed citations

Falardeau, Pierre, et al.. (2001). Autoreceptor preference of dopamine D2 receptor agonists correlates with preferential coupling to cyclic AMP. Neuroreport. 12(7). 1473–1479. 4 indexed citations

Falardeau, Pierre. (2001). Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials. Seminars in Oncology. 28(6). 620–625. 89 indexed citations

Côté, Stéphane, et al.. (2000). Cellular colocalization of dopamine D1 mRNA and D2 receptor in rat brain using a D2 dopamine receptor specific polyclonal antibody. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 24(7). 1127–1149. 38 indexed citations

Moszczyńska, Anna, Pierre Falardeau, Kathryn S. Kalasinsky, et al.. (2000). Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users. Molecular Psychiatry. 5(6). 664–672. 64 indexed citations

Isenring, Paul, Marcel Lebel, Pierre Falardeau, & John H. Grose. (1996). Eicosanoid modulation of the norepinephrine effect on blood pressure and renal hemodynamics in humans. Prostaglandins Leukotrienes and Essential Fatty Acids. 54(1). 59–63. 7 indexed citations

Sato, Noriyuki, et al.. (1995). Pituitary PRL secretion induced by tetraethylammonium is inhibited by dopamine through D2 receptors. Molecular and Cellular Endocrinology. 112(2). 153–157. 7 indexed citations

10.

Allard, Stéphane, Michel Labbé, & Pierre Falardeau. (1995). Recombination of endogenous D2 dopamine receptor gene with a metallothionein promoter in GH4C1 cells confers functional and inducible D2 response. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1260(1). 43–48. 1 indexed citations

11.

Missale, Cristina, F. Boroni, Sandra Sigala, et al.. (1994). Epidermal Growth Factor Promotes Uncoupling from Adenylyl Cyclase of the Rat D_2SReceptor Expressed in GH4C1 Cells. Journal of Neurochemistry. 62(3). 907–915. 7 indexed citations

12.

Gingrich, Jay A., Allen Dearry, Pierre Falardeau, et al.. (1992). Location and molecular cloning of D1 dopamine receptor. Neurochemistry International. 20. 9–15. 18 indexed citations

13.

Falardeau, Pierre, et al.. (1992). Inhibition of vasopressin-induced formation of diradylglycerols in vascular smooth muscle cells by incorporation of eicosapentaenoic acid in membrane phospholipids. Journal of Hypertension. 10(10). 1145–1153. 18 indexed citations

14.

Falardeau, Pierre, et al.. (1990). Resistance of the renal biosynthesis of prostaglandin E2 to the inhibitory effect of indomethacin in the rat in vivo. Prostaglandins Leukotrienes and Essential Fatty Acids. 41(2). 83–87. 5 indexed citations

15.

Bates, Michael D., Jay A. Gingrich, James R. Bunzow, et al.. (1990). Molecular Characterization of Dopamine Receptors. American Journal of Hypertension. 3(6_Pt_2). 29S–33S. 7 indexed citations

16.

Falardeau, Pierre, et al.. (1989). Antihypertensive Properties of Linoleic Acid and Fish Oil Omega-3 Fatty Acids Independent of the Prostaglandin System. American Journal of Hypertension. 2(8). 610–617. 30 indexed citations

17.

Lebel, Marcel, John H. Grose, & Pierre Falardeau. (1989). Modulation of renal hemodynamics by renal eicosanoids during vasopressor infusions in man. Prostaglandins Leukotrienes and Essential Fatty Acids. 35(1). 41–49. 11 indexed citations

18.

Rouillard, Claude, Paul J. Bédard, Pierre Falardeau, & Thérèse Di Paolo. (1988). Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion. European Journal of Pharmacology. 157(2-3). 125–133. 27 indexed citations

19.

Falardeau, Pierre, Sylvie Bouchard, Paul J. Bédard, R. Boucher, & Thérèse Di Paolo. (1988). Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys. European Journal of Pharmacology. 150(1-2). 59–66. 74 indexed citations

20.

Rouillard, Claude, P BEDARD, Pierre Falardeau, & Thérèse Di Paolo. (1987). Behavioral and biochemical evidence for a different effect of repeated administration of l-DOPA and bromocriptine on denervated versus non-denervated striatal dopamine receptors. Neuropharmacology. 26(11). 1601–1606. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact